Morning Overview on MSN
Atezolizumab plus chemo won FDA approval for some stage III colon cancers
On Oct. 8, 2026, the Food and Drug Administration approved atezolizumab, sold as Tecentriq by Genentech, together with chemotherapy for adults and children as young as two with Stage III colon cancer ...
Peer-Reviewed Paper Introduces QRX003 and Its Mechanism of Action in Netherton SyndromeCase Report Details Professor Alan Irvine’s Clinical ...
A new ultrasound-based index summing ossification ratios of the distal radius, distal ulna, and proximal radius correlates ...
Potentially accelerates development, assessment, and review for approval by FDASepsis impacts about 1.7 million U.S. adults annually and ...
Detecting impaired motor function as early as possible after birth with the help of a standard camera linked to intelligent ...
Children, Families, and the 2026 Revised Blood Guidance for Jehovah's Witnesses - An Update for Pediatric Hematology and ...
Once you exit the Keihan ticket gate, the roads around Gotenyama Station (Hirakata City, Osaka Prefecture) begin to incline ...
A new commentary in Pediatric Research evaluates whether the Aggregate Index of Systemic Inflammation, calculated from ...
NPR warns about politics shaping science at the HHS while ignoring over a decade of how left-wing politics shaped gender ...
When you exit the Keihan ticket gate, the area around Hirakatakoen Station (Hirakata City, Osaka Prefecture) opens up into ...
Quoin Pharmaceuticals publishes a paper on QRX003 for Netherton Syndrome, detailing positive pediatric case report outcomes. Quoin Pharmaceuticals has announced the acceptance of a peer-reviewed paper ...
Campbell Clinic is expanding its Center for Bone Health to help more patients recognize that warning, understand why their bones are vulnerable and receive treatment designed to reduce future fracture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results